Published in Proc Am Thorac Soc on August 15, 2009
Challenges in design and characterization of ligand-targeted drug delivery systems. J Control Release (2012) 1.07
Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo. J Control Release (2012) 0.94
Caveolae-dependent and -independent uptake of albumin in cultured rodent pulmonary endothelial cells. PLoS One (2013) 0.86
Assessing the barriers to image-guided drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.86
Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
Microparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae. PLoS One (2016) 0.75
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics (2002) 30.58
A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem (2004) 19.20
Caveolin, a protein component of caveolae membrane coats. Cell (1992) 12.50
Genes expressed in human tumor endothelium. Science (2000) 10.75
Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics (2005) 10.67
Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science (1985) 10.42
Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol (2001) 8.93
Proteomic characterization of the human centrosome by protein correlation profiling. Nature (2003) 8.74
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (2001) 8.53
Shedding light onto live molecular targets. Nat Med (2003) 8.47
Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics (2005) 8.14
Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci (1998) 7.88
Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res (2006) 6.43
Regulated internalization of caveolae. J Cell Biol (1994) 5.77
Dynamin-mediated internalization of caveolae. J Cell Biol (1998) 5.26
Separation of caveolae from associated microdomains of GPI-anchored proteins. Science (1995) 5.25
Organ targeting in vivo using phage display peptide libraries. Nature (1996) 5.20
Astrocytes induce blood-brain barrier properties in endothelial cells. Nature (1987) 4.70
Caveolae: from cell biology to animal physiology. Pharmacol Rev (2002) 4.45
Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol (1998) 3.99
Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J Biol Chem (1994) 3.67
Studies on blood capillaries. I. General organization of blood capillaries in muscle. J Cell Biol (1968) 3.65
Quantitative proteomics analysis of the secretory pathway. Cell (2006) 3.63
Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol (1983) 3.60
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
Genes that distinguish physiological and pathological angiogenesis. Cancer Cell (2007) 3.35
Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway. Proc Natl Acad Sci U S A (1987) 3.33
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol (2004) 2.98
Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis. J Cell Biol (1986) 2.73
Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol (1992) 2.72
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest (1998) 2.65
Integral and peripheral protein composition of the apical and basolateral membrane domains in MDCK cells. J Membr Biol (1989) 2.65
Early events in polyoma virus infection: attachment, penetration, and nuclear entry. J Virol (1976) 2.65
Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem (1995) 2.41
Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest (1994) 2.35
Transcytosis of albumin in capillary endothelium. J Cell Biol (1987) 2.33
Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal Chem (2002) 2.27
Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail--chick transplantation chimeras. Dev Biol (1981) 2.24
Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J (1995) 2.23
Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? J Cell Sci (1988) 2.16
Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol Cell Proteomics (2006) 2.11
Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science (1996) 1.95
Endothelial plasmalemmal vesicles have a characteristic striped bipolar surface structure. J Cell Biol (1985) 1.94
Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res (2003) 1.90
Quantitative proteomic analysis of Myc oncoprotein function. EMBO J (2002) 1.89
Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J Virol (2001) 1.79
Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol Med Today (1999) 1.75
Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol (1997) 1.74
The complexity of endothelial cells. A review. Am J Clin Pathol (1989) 1.73
Proteomics. Proteomics ponders prime time. Science (2008) 1.72
Association of the caveola vesicular system with cellular entry by filoviruses. J Virol (2002) 1.72
Morphometric data on the endothelium of blood capillaries. J Cell Biol (1974) 1.62
Cell biology of endothelial cells. Hum Pathol (1987) 1.54
Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol (2003) 1.46
Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci U S A (2005) 1.46
Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells (1991) 1.45
Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A (2002) 1.43
Biotinylation: an alternative to radioiodination for the identification of cell surface antigens in immunoprecipitates. Mol Immunol (1987) 1.42
Specific albumin binding to microvascular endothelium in culture. Am J Physiol (1988) 1.37
In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature. Nat Methods (2005) 1.32
In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium. J Nucl Med (2007) 1.30
Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev (2001) 1.28
Differential expression of cell surface glycoproteins on various organ-derived microvascular endothelia and endothelial cell cultures. J Cell Physiol (1988) 1.27
Immunoisolation of caveolae with high affinity antibody binding to the oligomeric caveolin cage. Toward understanding the basis of purification. J Biol Chem (1999) 1.26
Simian virus 40 infection via MHC class I molecules and caveolae. Immunol Rev (1999) 1.25
Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol Cell Proteomics (2007) 1.24
Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience (2008) 1.24
Protein microarray technology. Drug Discov Today (2002) 1.23
Monoclonal antibodies to E92, an endothelial cell surface antigen. Arteriosclerosis (1983) 1.21
Heterogeneity of mouse vascular endothelium. In vitro studies of lymphatic, large blood vessel and microvascular endothelial cells. Blood Vessels (1987) 1.21
Label-free quantitative analysis of one-dimensional PAGE LC/MS/MS proteome: application on angiotensin II-stimulated smooth muscle cells secretome. Mol Cell Proteomics (2008) 1.20
Transendothelial transport of serum albumin: a quantitative immunocytochemical study. J Cell Biol (1992) 1.14
Endothelial albumin binding proteins are membrane-associated components exposed on the cell surface. J Biol Chem (1989) 1.08
Amino acid-coded tagging approaches in quantitative proteomics. Expert Rev Proteomics (2007) 1.06
Segmental differentiation of permeability, protein glycosylation, and morphology of cultured bovine lung vascular endothelium. Biochem Biophys Res Commun (1994) 1.05
Endothelial regeneration: studies with human endothelial cells in culture. Ser Haematol (1973) 1.04
Transcytosis in the continuous endothelium of the myocardial microvasculature is inhibited by N-ethylmaleimide. Proc Natl Acad Sci U S A (1994) 1.04
An N-cadherin-like protein contributes to solute barrier maintenance in cultured endothelium. J Cell Physiol (1993) 1.03
Phorbol ester-induced disruption of the CD4-Lck complex occurs within a detergent-resistant microdomain of the plasma membrane. Involvement of the translocation of activated protein kinase C isoforms. J Biol Chem (1999) 1.03
NEM inhibits transcytosis, endocytosis, and capillary permeability: implication of caveolae fusion in endothelia. Am J Physiol (1995) 1.01
Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo. Mol Cell Proteomics (2009) 0.99
An investigation of some properties of endothelium related to capillary permeability. Proc R Soc Lond B Biol Sci (1967) 0.98
Caveolae require intact VAMP for targeted transport in vascular endothelium. Am J Physiol (1999) 0.98
Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Biochem Biophys Res Commun (2000) 0.98
Size and distribution of endothelial plasmalemmal vesicles in consecutive segments of the microvasculature in cat skeletal muscle. Microvasc Res (1979) 0.97
A monoclonal antibody reacting with endothelial cells of budding vessels in tumors and inflammatory tissues, and non-reactive with normal adult tissues. Int J Cancer (1986) 0.95
Identification and relative quantification of membrane proteins by surface biotinylation and two-dimensional peptide mapping. Proteomics (2005) 0.95
Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide. J Immunol (1998) 0.91
Identification of endothelial cell-surface proteins as targets for diagnosis and treatment of disease. Nat Med (1996) 0.91
Characterization and differential expression of an endothelial cell-specific surface antigen in continuous and sinusoidal endothelial, in skin vascular lesions and in vitro. Exp Cell Biol (1989) 0.90
The adenosine 5',5"',P1,P4-tetraphosphate receptor is at the cell surface of heart cells. Biochemistry (1993) 0.89
Proteome analysis of migrating versus nonmigrating rat heart endothelial cells reveals distinct expression patterns. Endothelium (2003) 0.88
Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme. J Nucl Med (1991) 0.88
High resolution SPECT in small animal research. Rev Neurosci (2001) 0.87
Immunotoxins and vascular leak syndrome. Cancer J (2000) 0.87
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol (2009) 3.01
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol (2004) 2.98
Caveolae: mining little caves for new cancer targets. Nat Rev Cancer (2003) 1.76
Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am J Physiol Heart Circ Physiol (2003) 1.47
Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci U S A (2005) 1.46
Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A (2002) 1.43
Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol (2002) 1.21
Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.10
Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc Natl Acad Sci U S A (2009) 1.00
Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo. Mol Cell Proteomics (2009) 0.99
Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium. Am J Physiol Heart Circ Physiol (2004) 0.97
Application of capture-recapture models to estimation of protein count in MudPIT experiments. Anal Chem (2006) 0.96
Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo. J Biol Chem (2009) 0.95
T cell pathways involving CTLA4 contribute to a model of acute lung injury. J Immunol (2010) 0.94
Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol (2009) 0.92
Transient mechanoactivation of neutral sphingomyelinase in caveolae to generate ceramide. J Biol Chem (2002) 0.90
Role of caveolae and lipid rafts in cancer: workshop summary and future needs. Cancer Res (2003) 0.90
Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int J Nanomedicine (2010) 0.90
Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-inducible transcription factor complex. J Am Chem Soc (2013) 0.89
Genomics and proteomics of lung disease: conference summary. Am J Physiol Lung Cell Mol Physiol (2007) 0.88
Assessing the barriers to image-guided drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.86
Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues. Mol Cell Proteomics (2010) 0.84
Endothelin induces rapid, dynamin-mediated budding of endothelial caveolae rich in ET-B. J Biol Chem (2012) 0.84
Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat. J Vasc Res (2009) 0.83
Caveolae and cancer. Recent Results Cancer Res (2010) 0.82
Streamlining biomarker discovery. Nat Biotechnol (2011) 0.79
Chapter 8. Proteomic mapping of the vascular endothelium in vivo for vascular targeting. Methods Enzymol (2008) 0.79
Range Charts for Agreement in Measurement Comparison Studies, With Application to Replicate Mass Spectrometry Experiments. J Proteomics Bioinform (2008) 0.76
Systems analysis of endothelial cell plasma membrane proteome of rat lung microvasculature. Proteome Sci (2011) 0.76
Laser-targeted photosensitizer-induced lung injury: noninvasive rat model of pulmonary infarction. Exp Lung Res (2011) 0.76
Tumor targeting, trifunctional dendritic wedge. Bioconjug Chem (2014) 0.75
Construction of metabolically biotinylated adenovirus with deleted fiber knob as targeting vector. Virol J (2010) 0.75
Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction. Am J Physiol Heart Circ Physiol (2013) 0.75